• 1. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 2. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 3. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 4. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to n-Cyclopentyl-2-methylalaninamide Hydrochloride (CAS No 1220019-33-9)

n-Cyclopentyl-2-methylalaninamide Hydrochloride, with the CAS number 1220019-33-9, is a specialized compound that has garnered significant attention in the field of pharmaceutical chemistry and biomedicine. This compound, characterized by its unique structural framework, exhibits promising properties that make it a valuable candidate for various research applications, particularly in the development of novel therapeutic agents.

The molecular structure of n-Cyclopentyl-2-methylalaninamide Hydrochloride incorporates a cyclopentyl group and a methylalaninamide moiety, which contribute to its distinct chemical and biological characteristics. The presence of these functional groups enhances its solubility and bioavailability, making it an attractive candidate for drug formulation and delivery systems. Recent studies have highlighted its potential role in modulating biological pathways, particularly those involving inflammation and pain management.

In the realm of academic research, n-Cyclopentyl-2-methylalaninamide Hydrochloride has been investigated for its potential applications in treating chronic inflammatory conditions. Its ability to interact with specific enzymatic targets has been demonstrated in preclinical studies, suggesting its efficacy in reducing inflammation without the adverse effects associated with some traditional anti-inflammatory drugs. This has opened up new avenues for therapeutic intervention in conditions such as rheumatoid arthritis and inflammatory bowel disease.

The compound's unique structural features also make it a valuable tool in drug discovery and development. Researchers have leveraged its chemical properties to design and synthesize derivatives with enhanced pharmacological activity. For instance, modifications to the cyclopentyl ring have been explored to improve binding affinity to target receptors, while alterations to the amide group have aimed at optimizing metabolic stability. These efforts have led to the identification of novel compounds with improved therapeutic profiles.

Moreover, n-Cyclopentyl-2-methylalaninamide Hydrochloride has shown promise in clinical trials as a potential treatment for neurological disorders. Its ability to cross the blood-brain barrier has been a key focus of research, as this property is crucial for effective treatment of central nervous system disorders. Preliminary findings suggest that it may have neuroprotective effects, making it a candidate for conditions such as Alzheimer's disease and Parkinson's disease. These findings are particularly encouraging given the growing burden of neurodegenerative diseases worldwide.

The synthesis and purification of n-Cyclopentyl-2-methylalaninamide Hydrochloride are critical aspects that ensure its quality and efficacy. Advanced synthetic methodologies have been developed to produce high-purity batches of the compound, which are essential for rigorous testing and validation in both preclinical and clinical settings. Collaborative efforts between academic institutions and pharmaceutical companies have facilitated these advancements, leading to more efficient and scalable production processes.

The safety profile of n-Cyclopentyl-2-methylalaninamide Hydrochloride has also been extensively evaluated through comprehensive toxicological studies. These studies have assessed its acute and chronic toxicity, as well as its potential for long-term adverse effects. The results have been reassuring, indicating that the compound is well-tolerated at therapeutic doses. However, ongoing research is necessary to fully understand its safety profile across diverse populations and therapeutic contexts.

In conclusion, n-Cyclopentyl-2-methylalaninamide Hydrochloride represents a significant advancement in pharmaceutical chemistry and biomedicine. Its unique structural properties, coupled with promising preclinical and clinical findings, position it as a valuable compound for further research and development. As our understanding of biological pathways continues to evolve, compounds like this one will play an increasingly important role in the discovery and treatment of various diseases.

• 90058-29-0((S)-8-Methyl-6,9-diazaspiro[4.5]decane-7,10-dione)
• 90104-11-3(Glycinamide, N-(cyclopentylcarbonyl)-2-methyl-D-leucyl-)
• 1220029-00-4(2-Amino-N-cyclohexyl-2-methylpropanamide hydrochloride)
• 1220034-26-3(2-Amino-N-butyl-2-methylpropanamide hydrochloride)
• 1220029-93-5(2-Amino-N-(sec-butyl)-2-methylpropanamide hydrochloride)
• 1214638-91-1(2-amino-N-cyclopentyl-propanamide;hydrochloride)
• 4854-56-2(Cyclopentanecarboxamide,1-(acetylamino)-)
• 90104-10-2(Glycinamide, N-(cyclopentylcarbonyl)-2-methyl-L-leucyl-)
• 189366-85-6(Cyclopentanecarboxamide,1-[(2-aminoacetyl)amino]-)
• 177219-40-8(1-Pentanamidocyclopentanecarboxamide)